A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
Public ClinicalTrials.gov record NCT03126019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Open-Label Study of INCB050465, a PI3Kδ Inhibitor in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
Study identification
- NCT ID
- NCT03126019
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- 126 participants
Conditions and interventions
Conditions
Interventions
- Parsaclisib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 13, 2018
- Primary completion
- Feb 25, 2021
- Completion
- Jun 6, 2024
- Last update posted
- Mar 13, 2025
2018 – 2024
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates - Biltmore Cancer Center | Phoenix | Arizona | 85016 | — |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | — |
| Synergy Hematology and Oncology Medical Associates | Los Angeles | California | 90036 | — |
| St. Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| American Institute of Research Corporate Office | Whittier | California | 90603 | — |
| Cancer Center of Central Connecticut | Southington | Connecticut | 06489 | — |
| Florida Cancer Specialists & Research Institute | Fort Myers | Florida | 33901 | — |
| Asclepes Research Centers | Spring Hill | Florida | 34606 | — |
| Clinical Trials of Swla Llc | Lake Charles | Louisiana | 70601 | — |
| Saint Agnes Hospital | Baltimore | Maryland | 21229 | — |
| Barbara Ann Karmanos Cancer Hospital | Detroit | Michigan | 48201 | — |
| Hattiesburg Clinic Hematology | Hattiesburg | Mississippi | 39401 | — |
| Saint Luke'S Hospital | Kansas City | Missouri | 64111 | — |
| Sarah Cannon Research Institute | Kansas City | Missouri | 64132 | — |
| Clinical Research Alliance, Inc. | New Hyde Park | New York | 11042 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| University of Pennsylvania Health System | Philadelphia | Pennsylvania | 19104 | — |
| Charleston Hematology Oncology Associates Pa | Charleston | South Carolina | 29414 | — |
| Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| Renovatio Clinical Consultants Llc | Spring | Texas | 77380 | — |
| University of Washington | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03126019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 13, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03126019 live on ClinicalTrials.gov.